These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3932219)

  • 1. Monoclonal antibodies: technology and application to gram-negative infections.
    Young LS
    Infection; 1985; 13 Suppl 2():S224-9. PubMed ID: 3932219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies: technology and application to gram-negative infections.
    Young LS
    Infection; 1984; 12(4):303-8. PubMed ID: 6208152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
    J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of gram-negative bacteria for Pseudomonas aeruginosa lipoprotein I using a monoclonal antibody.
    Sciortino CV
    Hybridoma; 1993 Jun; 12(3):327-32. PubMed ID: 7689535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.
    Bogard WC; Dunn DL; Abernethy K; Kilgarriff C; Kung PC
    Infect Immun; 1987 Apr; 55(4):899-908. PubMed ID: 3549565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies for treatment of gram-negative infections.
    Young LS; Gascon R; Alam S; Bermudez LE
    Rev Infect Dis; 1989; 11 Suppl 7():S1564-71. PubMed ID: 2690294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
    Mutharia LM; Crockford G; Bogard WC; Hancock RE
    Infect Immun; 1984 Sep; 45(3):631-6. PubMed ID: 6381310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a protective human monoclonal for the treatment of gram-negative sepsis.
    Larrick JW; Gray O; Deinhart T; Wang J; Flatgaard J; Chong KT
    Prog Clin Biol Res; 1988; 272():383-93. PubMed ID: 3393571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic epitope in Pseudomonas aeruginosa lipopolysaccharide immunologically cross-reactive with Escherichia coli O26 lipopolysaccharide.
    Yokota S; Kaya S; Noguchi H
    FEMS Microbiol Lett; 1990 Mar; 56(3):245-8. PubMed ID: 1692796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic homology among gram-negative organisms isolated from cattle with clinical mastitis.
    Tyler J; Spears H; Cullor J; Smith W; Nelson R; Martin J
    J Dairy Sci; 1991 Apr; 74(4):1235-42. PubMed ID: 1907303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and potential use of antibody directed against lipopolysaccharide for the treatment of gram-negative bacterial sepsis.
    Dunn DL
    J Trauma; 1990 Dec; 30(12 Suppl):S100-6. PubMed ID: 2254968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity targeting common core antigens of gram-negative bacteria.
    Tyler JW; Cullor JS; Spier SJ; Smith BP
    J Vet Intern Med; 1990; 4(1):17-25. PubMed ID: 2407840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide.
    de Kievit TR; Lam JS
    J Bacteriol; 1994 Dec; 176(23):7129-39. PubMed ID: 7525538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide.
    Priest BP; Brinson DN; Schroeder DA; Dunn DL
    Surgery; 1989 Aug; 106(2):147-54; discussion 154-5. PubMed ID: 2763023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection.
    Dunn DL; Ewald DC; Chandan N; Cerra FB
    Arch Surg; 1986 Jan; 121(1):58-62. PubMed ID: 3942500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of two surface-localized antigenic sites on porin protein F of Pseudomonas aeruginosa.
    Mutharia LM; Hancock RE
    Can J Microbiol; 1985 Apr; 31(4):381-6. PubMed ID: 2408719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of monoclonal antibody therapy in the treatment of infectious disease.
    Chmel H
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S11-5. PubMed ID: 2275476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R-form lipopolysaccharides (LPS) of Gram-negative bacteria as possible vaccine antigens.
    Stanislavsky ES; Makarenko TA; Kholodkova EV; Lugowski C
    FEMS Immunol Med Microbiol; 1997 Jul; 18(3):139-45. PubMed ID: 9271164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.